Earnings History Data for Oncolytics Biotech Inc. (ONCY) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Oncolytics Biotech Inc.

Oncolytics Biotech, Inc. focuses on the discovery and development of pharmaceutical products for the treatment of a wide variety of human and companion pet cancers. The Company was formed to explore the oncolytic capability of the reovirus, a virus that preferentially replicates in cells with an activated Ras pathway, one of the most common family of genetic defects leading to cancer.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
12-11-2024	PM		ONCY	Oncolytics Biotech Inc.	82.38	-0.09	-0.08	-0.10	Oncolytics Biotech GAAP EPS of -$0.12 misses by $0.04 [11/12/2024 7:24 AM]	1.11	0.03 (2.78%)	1.08	0.0 (0.00%)	0.84 - 1.75	539,798	300,000	6,526
Oncolytics Biotech GAAP EPS of -$0.12 misses by $0.04 [11/12/2024 7:24 AM] Oncolytics Biotech Reports Third Quarter 2024 Financial Results and Operational Highlights [2024-11-12 07:00AM] Oncolytics Biotech to Host Conference Call to Discuss Third Quarter Financial Results and Recent Operational Highlights [Nov-11-24 07:00AM]
01-08-2024	AH		ONCY	Oncolytics Biotech Inc.	79.65	-0.07	-0.08	-0.09	Oncolytics Biotech GAAP EPS of -$0.10 misses by $0.03 [8/1/2024 5:04 PM]	1.01	-0.02 (-1.94%)	1.02	-0.01 (-0.97%)	0.88 - 2.49	416,601	110,000	1,404
Oncolytics Biotech GAAP EPS of -$0.10 misses by $0.03 [8/1/2024 5:04 PM]
09-05-2024	AH		ONCY	Oncolytics Biotech Inc.	89.75	-0.07	-0.09	-0.07	Oncolytics Biotech GAAP EPS of -$0.09 misses by $0.01 [5/9/2024 4:25 PM]	1.17	-0.07 (-6.05%)	1.20	-0.04 (-3.19%)	0.88 - 3.39	321,238	200,000	3,243
Oncolytics Biotech GAAP EPS of -$0.09 misses by $0.01 [5/9/2024 4:25 PM]
07-03-2024	AH		ONCY	Oncolytics Biotech Inc.	75.57	-0.04	-0.11	-0.10	Oncolytics Biotech GAAP EPS of -$0.05 beats by $0.06 [3/7/2024 4:39 PM]	1.05	0.01 (0.96%)	1.06	0.02 (1.92%)	0.88 - 3.39	397,125	650,000	9,482
Oncolytics Biotech GAAP EPS of -$0.05 beats by $0.06 [3/7/2024 4:39 PM]
03-11-2023	PM		ONCY	Oncolytics Biotech Inc.	121.79	-0.10	-0.07	-0.06	Oncolytics Biotech GAAP EPS of -$0.14 misses by $0.06 [11/3/2023 7:09 AM]	1.71	-0.08 (-4.47%)	1.70	-0.09 (-5.03%)	1.09 - 3.39	458,376	440,000	18,759
Oncolytics Biotech GAAP EPS of -$0.14 misses by $0.06 [11/3/2023 7:09 AM]
14-08-2023	PM		ONCY	Oncolytics Biotech Inc.	135.66	-0.09	-0.09	-0.07	Oncolytics Biotech GAAP EPS of -C$0.12 [8/14/2023 9:05 AM]	2.05	0.02 (0.99%)	2.12	0.09 (4.43%)	1.09 - 3.39	650,218	1,050,000	11,139
Oncolytics Biotech GAAP EPS of -C$0.12 [8/14/2023 9:05 AM]
05-05-2023	PM	8:00 AM ET (May 5)	ONCY	Oncolytics Biotech Inc.	109.83	-0.07	-0.07	-0.09	Oncolytics Biotech GAAP EPS of -$0.10 in-line [5/5/2023 12:57 PM]	1.62	0.17 (11.72%)	1.53	0.08 (5.52%)	0.80 - 2.28	225,089	230,000	14,654
Oncolytics Biotech Q1 2023 Earnings Preview [5/4/2023 12:44 PM] Oncolytics Biotech GAAP EPS of -$0.10 in-line [5/5/2023 12:57 PM]
03-03-2023	PM	8:00 AM ET (Mar 3)	ONCY	Oncolytics Biotech Inc.	98.58	-0.11	-0.05	-0.11	Oncolytics Biotech GAAP EPS of -$0.14 misses by $0.07 [3/3/2023 7:23 AM]	1.60	-0.08 (-4.76%)	1.68	0.0 (0.00%)	0.80 - 2.28	298,564	160,000	29,555
Oncolytics Biotech GAAP EPS of -$0.14 misses by $0.07 [3/3/2023 7:23 AM]
07-11-2022	PM	7:00 AM ET (Nov 7)	ONCY	Oncolytics Biotech Inc.	72.33	-0.06	-0.09	-0.07	Oncolytics Biotech GAAP EPS of -C$0.08 in-line [11/7/2022 8:12 AM]	1.51	0.25 (20.24%)	1.43	0.17 (13.49%)	0.80 - 2.11	495,794	40,000	40,251
Oncolytics Biotech GAAP EPS of -C$0.08 in-line [11/7/2022 8:12 AM] Oncolytics Biotech® Reports Third Quarter 2022 Financial Results and Recent Operational Highlights [Nov-07-22 08:03AM] Oncolytics Biotech® Reports Interim Results from Phase 1/2 GOBLET Study Showing a 70% Objective Response Rate in Pancreatic Cancer at the SITC Annual Meeting [Nov-07-22 08:01AM]
11-08-2022	PM	7:00 AM ET (Aug 11)	ONCY	Oncolytics Biotech Inc.	60.68	-0.07	-0.09	-0.11	Oncolytics Biotech GAAP EPS of -$0.09 misses by $0.01 [8/11/2022 7:02 AM]	1.30	0.0 (0.00%)	1.35	0.05 (3.89%)	0.80 - 2.38	207,474	150,000	1,670
Oncolytics Biotech Q2 2022 Earnings Preview [8/10/2022 1:46 PM] Oncolytics Biotech GAAP EPS of -$0.09 misses by $0.01 [8/11/2022 7:02 AM]
05-05-2022	AH	4:00 PM ET (May 5)	ONCY	Oncolytics Biotech Inc.	79.39	-0.09	-0.13	-0.10	Oncolytics Biotech GAAP EPS of -$0.12 misses by $0.01 [5/5/2022 4:40 PM]	1.36	0.0 (0.00%)	1.33	-0.10 (-6.99%)	1.25 - 3.21	57,656	90,000	754
Oncolytics Biotech GAAP EPS of -$0.12 misses by $0.01 [5/5/2022 4:40 PM] Oncolytics Biotech® and SOLTI Present New Clinical Biomarker Data Demonstrating Pelareorep's Potential to Improve the Prognosis of Breast Cancer Patients at the ESMO Breast Cancer Meeting [May-04-22 07:00AM] Oncolytics Biotech® Reports First Quarter 2022 Financial Results and Recent Operational Highlights [May-05-22 04:01PM]
03-03-2022	AH	4:00 PM ET (Mar 3)	ONCY	Oncolytics Biotech Inc.	93.55	-0.11	-0.14	-0.16	Oncolytics Biotech GAAP EPS of -C$0.14 [3/3/2022 4:10 PM]	1.49	-0.13 (-8.02%)	1.73	0.01 (0.58%)	1.25 - 4.83	376,210	230,000	2,277
Oncolytics Biotech GAAP EPS of -C$0.14 [3/3/2022 4:10 PM] Oncolytics Biotech® Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Operational Highlights [Mar-03-22 04:01PM]
05-11-2021	PM	7:00 AM ET (Nov 5)	ONCY	Oncolytics Biotech Inc.	117.06	-0.07	-0.15	-0.12	Oncolytics Biotech reports Q3 results [11/5/2021 7:18 AM]	2.09	0.06 (2.96%)	2.20	0.17 (8.37%)	1.87 - 4.83	223,715	190,000	11,654
Oncolytics Biotech Q3 2021 Earnings Preview [11/4/2021 12:13 PM] Oncolytics Biotech reports Q3 results [11/5/2021 7:18 AM] Oncolytics rises premarket after Q3 2021 earnings beat, breast cancer data [11/5/2021 8:47 AM] Oncolytics Biotech® Reports 2021 Third Quarter Development Highlights and Financial Results [Nov-05-21 07:00AM]
06-08-2021	PM	7:00 AM ET (Aug 6)	ONCY	Oncolytics Biotech Inc.	94.56	-0.11	-0.10	-0.12	Oncolytics Biotech EPS misses by $0.03 [8/6/2021 7:34 AM]	2.23	0.04 (1.83%)	2.20	0.01 (0.46%)	1.52 - 4.83	226,753	150,000	13,122
Oncolytics Biotech EPS misses by $0.03 [8/6/2021 7:34 AM] Oncolytics Biotech® to Participate in Virtual Fireside Chat at the Canaccord Genuity 41st Annual Growth Conference [Aug-06-21 06:30AM] Oncolytics Biotech® Reports 2021 Second Quarter Development Highlights and Financial Results [Aug-06-21 07:00AM]
07-05-2021	PM		ONCY	Oncolytics Biotech Inc.	161.00	-0.10	-0.17	0.00	Oncolytics Biotech reports Q1 results [5/7/2021 7:39 AM]	2.86	-0.06 (-2.05%)	2.94	0.02 (0.69%)	1.52 - 4.83	888,013	580,000	6,861
Oncolytics Biotech reports Q1 results [5/7/2021 7:39 AM]
05-03-2021	PM	7:00 AM ET (Mar 5)	ONCY	Oncolytics Biotech Inc.	132.05	-0.16	-0.13	-0.19	Oncolytics Biotech EPS misses by $0.09 [3/5/2021 7:35 AM]	2.69	-0.36 (-11.81%)	3.09	0.04 (1.31%)	0.94 - 4.70	2,255,396	2,195,246	9,194
Oncolytics Biotech EPS misses by C$0.12 [3/5/2021 7:35 AM] Oncolytics Biotech secures $80M capital raise [3/5/2021 7:52 AM]
11-11-2020	AH	4:00 PM ET (Nov 11)	ONCY	Oncolytics Biotech Inc.	89.98	-0.12	0.00	-0.12	Oncolytics Biotech EPS misses by $0.06 [11/11/2020 4:02 PM]	2.12	-0.03 (-1.39%)	2.19	0.04 (1.86%)	0.82 - 6.02	289,908	428,496	42,132

04-08-2020	AH	4:00 PM ET (Aug 4)	ONCY	Oncolytics Biotech Inc.	81.79	-0.12	-0.15	-0.19	Oncolytics Biotech EPS misses by $0.06 [8/4/2020 4:04 PM]	2.00	-0.15 (-6.98%)	2.12	-0.03 (-1.40%)	0.35 - 6.02	654,070	480,154	10,523